18th Jan.

 

BioHourly.com is the subsidiary of 'Bio Hourly Limited' (UK Company number 10484196). We are international investment group dedicated exclusively to the life sciences and healthcare sectors. Since its founding in 2010, 'Bio Hourly Limited' has formed six venture capital funds, which total over $10 million and have invested in more than 136 biotech companies. Our specialist team of over 20 professionals has a broad range of skills, including scientific and medical expertise as well as investment, banking and legal knowledge. Our executive and advisory network's broad scientific and medical experience allow us to identify the most promising financial opportunities that exist in biotech industry.



Our management team is comprised of a deliberately small, but highly qualified and experienced core group of professionals who provide an outstanding blend of scientific and investment expertise, and a proven track record of delivering superb results for our investors.
 

Walter Davis, M.D., Ph.D. founder

Walter Davis is the founder and managing director of 'Bio Hourly Limited' Doctor Walter Davis has full-cycle investing experience, successfully sourcing, syndicating, managing and exiting investments. He graduated from Mount Sinai School of Medicine and received his Ph.D. in Biomedical Engineering from Columbia University. He received his M.B.A. from Columbia School of Business. Dr. Perelman holds a B.S. in Chemical Engineering and a B.S. in Biological Sciences.


Francis Newman co-founder

Francis Newman, is the co-founder and the senior partner of 'Bio Hourly Limited' Dr. Newman has a background as a biotech entrepreneur, biotech intellectual property rights expert and business development executive, combined with a scientific career. He has been actively involved in biotech investment since the late 1990's. Dr. Newman holds an MSc in chemical engineering, a PhD in molecular biology biochemistry and an MBA.


Vera Schormann, Scientific advisor

Ms. Schormann has a strong background in chemical research and analysis, and a superb track record of successful project leadership. She received her M.Sc. in Pharmaceutical Sciences from the University of Greenwich, and her B.Sc. in Chemistry from the University of Guelph.


Howard Sumner, Investment expert

Howard Sumner has been the investment expert of 'Bio Hourly Limited' since the company formation in 2010.
Howard has over 20 years of experience in private equity and investment banking. He has in-depth experience investing in healthcare industry throughout his career.
Mr. Howard holds a BA and a MBA from Cornell University.


  Running days: 31
  Total members:  11107
  Total deposit: $1764285.45
  Total withdraw: $846406.38